Uncovering Novel Microenvironmental Targets for Radiopharmaceutical Development

Time: 1:15 pm
day: Day Two Discovery PM


  • Targeting stromal cells in tumor and metastatic masses, attractive targets for radiopharmaceutical ablation
  • Evaluating a novel high affinity antibody platform targeting LRRC15 in preclinical systems
  • Exploring cross reaction with humans for targeted imaging and therapy of aggressive treatment refractory cancers of mesenchymal lineage